Efficacy of Pain Monitor, a Smartphone App for Chronic Pain

NCT ID: NCT03247725

Last Updated: 2018-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-01

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present investigation aims at exploring the effect of including a pain app called Pain Monitor for chronic pain patients' daily monitoring. Three conditions will be set:

1. usual treatment (waiting list)
2. usual treatment + app (without alarms)
3. usual treatment + app (with alarms)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic pain is defined as one that lasts for at least three to six months, provided that this time is greater than the normal healing period of an injury. This pathology has become an important public health problem due to its high prevalence. In particular, it is estimated that it affects 20-30% of the adult population around the world. Medical interventions are the first-line treatment in recent clinical practice guidelines. Unfortunately, the effectiveness of medical interventions is only modest. Treatments significantly reduce pain on average, but the effect tends to be small . In addition, the drugs are not effective for a large percentage of patients.

What these and other research suggest is that focusing only on large sample studies and the use of average change scores calls into question the usefulness of current patient-centered treatments. As noted by Dr. Turk, when data are averaged, various pain syndromes, drugs, surgical procedures, and studies in different countries are often included, which may mask the efficacy results of different treatments with Different samples. Single case methodology could be one of the ways to overcome these limitations. The single case investigation is a type of experimental study that offers experimental control within a single case.

Some studies have already demonstrated the usefulness of these designs in chronic pain. In fact, the benefits of using this methodology as opposed to large sample studies were discussed recently during the 10th Congress of the European Pain Federation. These benefits include the need for a reduced number of participants, the ability to follow clinical evolution in real time and continuously, the amount of data provided, and applicability when using a control group is impractical or unethical.

The investigators conducting the present investigation recently conducted a study at the Pain Unit of the Vall d'Hebron Hospital to explore the effectiveness of current medical treatments. According to previous investigations, the treatment effect was only small (d = 0.32) and only a percentage of the patients (18.1%) had a clinically significant reduction of pain (ie a reduction greater than 30% ).

From these results and the literature reviewed, a single case design could be an alternative method for research in the Pain Unit. However, the implementation of this type of methodology can be very costly due to the continuous evaluation of the evolution of the patient. In this sense, several studies have already shown that mobile applications (app) can effectively control the evolution of a wide range of pathologies in health settings . In fact, a recent controlled clinical study found that ecological records performed with mobile app had greater reliability than paper-and-pencil records.

Rosser and Eccleston conducted a comprehensive review of existing apps for pain and the conclusion was that there was little evidence to support the use of current apps. Specifically, these authors showed that most apps did not specify whether their content was validated, did not include psychological components and none had been applied in a clinical study. In light of these results, Dr. Carlos Suso Ribera and Dr. Ribera Canudas contacted the research team Labpsitec of Jaume I University, who were developing an application for pain called "Pain Monitor". Dr. Carlos Suso Ribera and Dr. Ribera Canudas of the Pain Unit collaborated with Dr. Azucena García Palacios and Dr. Diana Castilla López of the Universitat Jaume I in the final development of the application of pain, Following the guidelines of Rosser and Eccleston.

App content validity and usability was tested in a previous study at the pain unit of the Vall d'Hebron Hospital (Suso-Ribera et al., in preparation). Thus, the study objective is to test if the introduction of this tool in the day-to-day work of the pain unit improves pain management of chronic pain patients. To do this, it is necessary to compare the evolution of patients who follow the usual treatment at the pain unit (without app) with a group of patients who do use the Pain Monitor app. In addition, the present study investigators have created a new utility that allows alarms to be generated by healthcare professionals in the presence of an undesired event, such as an adverse effect of the medication or a lack of response to medical treatment. Before determining that both the use of the app and this new utility (alarms) are beneficial for patient care, it is necessary to perform a clinical trial comparing the 3 conditions mentioned above:

1. usual treatment (waiting list)
2. usual treatment + app (without alarms)
3. usual treatment + app (with alarms) Therefore, this is a clinical trial without drugs. This is not an observational study since the physicians of patients in the app + alarms condition will be asked to react to an alarm (i.e., if the patient has nausea for 3 consecutive days) by calling the patient and changing the treatment telematically, if necessary, so that the patient can collect the prescription at his primary care center.

If the condition app with alarms results in a better treatment of chronic pain patients, participants of the other two conditions will be offered the possibility to use the app with alarms at the end of the study.

The study will be conducted at the Pain Unit of the Vall d'Hebron Hospital. All study procedures have been approved by the ethical committee of the Vall d'Hebron Hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Three conditions. Patients will be randomly assigned to one of the three conditions.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Patients will be informed of the condition they have been assigned to.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment as usual (waiting list)

Patients at this condition will receive the usual medical treatment at the pain unit, but they will not be monitored daily using the app.

Group Type ACTIVE_COMPARATOR

Treatment as usual (medical)

Intervention Type OTHER

Patients will be offered the usual treatment for their pain, which is not changed by study participation

Treatment as usual + app (without alarm)

Participants at this condition will receive the usual medical treatment for their pain but also they will be monitored daily using the Pain Monitor app. Because alarms will not be generated, physicians will not know if an undesired event is occuring despite the app is actually collecting data.

Group Type EXPERIMENTAL

pain app

Intervention Type OTHER

Pain Monitor app has been developed by a multidisciplinary pain expert panel, including physicians, psychologists, and nurses. Content has been validated in a previous study and usability has been shown to be excellent.

Treatment as usual (medical)

Intervention Type OTHER

Patients will be offered the usual treatment for their pain, which is not changed by study participation

Treatment as usual + app (with alarm)

Participants at this condition will receive the usual medical treatment for their pain but also they will be monitored daily using the Pain Monitor app. Alarms will be generated in the face of certain preestablished events. Physicians will be asked to call patients and change/stop treatment if an alarm is received.

Group Type EXPERIMENTAL

pain app

Intervention Type OTHER

Pain Monitor app has been developed by a multidisciplinary pain expert panel, including physicians, psychologists, and nurses. Content has been validated in a previous study and usability has been shown to be excellent.

Treatment as usual (medical)

Intervention Type OTHER

Patients will be offered the usual treatment for their pain, which is not changed by study participation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pain app

Pain Monitor app has been developed by a multidisciplinary pain expert panel, including physicians, psychologists, and nurses. Content has been validated in a previous study and usability has been shown to be excellent.

Intervention Type OTHER

Treatment as usual (medical)

Patients will be offered the usual treatment for their pain, which is not changed by study participation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient is over 18 years of age
* The patient has a mobile phone with Android operating system
* The patient has the physical ability to use the application
* The patient does not present psychological and / or cognitive alterations or problems with language that make their participation difficult
* The patient voluntarily wants to participate and signs the informed consent

Exclusion Criteria

* The patient is under 18 years
* The patient does not have a mobile phone or has a mobile phone in which Android is not the operating system (the app is currently only available for Android for economic reasons)
* The patient does not have the physical capacity to use the application
* The patient does not have the capacity to participate due to psychological and / or cognitive alterations or problems with language
* The patient does not want to participate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitat Jaume I

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carlos Suso Ribera

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ángela Mesas Idáñez, MD

Role: PRINCIPAL_INVESTIGATOR

Staff Doctor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vall d'Hebron Hospital

Barcelona, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Rosser BA, Eccleston C. Smartphone applications for pain management. J Telemed Telecare. 2011;17(6):308-12. doi: 10.1258/jtt.2011.101102. Epub 2011 Aug 15.

Reference Type BACKGROUND
PMID: 21844177 (View on PubMed)

Suso-Ribera C, Mesas A, Medel J, Server A, Marquez E, Castilla D, Zaragoza I, Garcia-Palacios A. Improving pain treatment with a smartphone app: study protocol for a randomized controlled trial. Trials. 2018 Feb 27;19(1):145. doi: 10.1186/s13063-018-2539-1.

Reference Type DERIVED
PMID: 29482614 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UJI_PainMonitor

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Living Well with Chronic Pain
NCT03705104 ACTIVE_NOT_RECRUITING NA